Home LiteratureArticle Details
PMID: 27275318 Published · ppublish English Journal Article Review

Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment.

Open access Macedonian journal of medical sciences ·Vol. 3 ·No. 4 ·2015-12-15 ·Pages 732-6

Janevska D, Chaloska-Ivanova V, Janevski V

Abstract

Hepatocellular carcinoma (HCC) is the most often primary cancer of the liver and is one if the leading cause of cancer-related death worldwide. The incidence of HCC has geographic distribution with the highest levels in countries with developing economies. Patients with hepatocellular carcinoma have poor prognosis despite the achievements in surgery techniques and other therapeutic procedures and it is a reason why continuous attention should be paid to this issue. This article provides an overview of this disease based on an extensive review of relevant literature. The article summarizes the current risk factors, diagnosis, staging and the management of HCC.

Keywords
diagnosis hepatocellular carcinoma management review article risk factors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Janevska Dafina
University Clinic of Gastroenterohepatology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
Chaloska-Ivanova Viktorija
University Clinic of Gastroenterohepatology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
Janevski Vlado
University Clinic of Abdominal Surgery, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
References (31)
31 references, click to expand
  1. World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective.
    J Gastrointestin Liver Dis. 2010 Sep;19(3):311-7 PMID: 20922197
  2. Management of hepatocellular carcinoma: an update.
    Hepatology. 2011 Mar;53(3):1020-2 PMID: 21374666
  3. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass.
    Liver Transpl. 2005 Mar;11(3):281-9 PMID: 15719410
  4. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.
    Clin Gastroenterol Hepatol. 2006 Mar;4(3):369-80 PMID: 16527702
  5. Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.
    Biochemistry (Mosc). 2008 May;73(5):504-13 PMID: 18605975
  6. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis.
    Pathol Oncol Res. 2004;10(1):5-11 PMID: 15029254
  7. Global cancer statistics, 2002.
    CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 PMID: 15761078
  8. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.
    Gut. 2003 May;52 Suppl 3:iii1-8 PMID: 12692148
  9. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
    Hepatology. 2010 Jun;51(6):1972-8 PMID: 20209604
  10. Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma.
    Mol Clin Oncol. 2014 Mar;2(2):203-206 PMID: 24649333
  11. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials.
    Ann Oncol. 1997 Feb;8(2):117-36 PMID: 9093719
  12. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.
    Ann Oncol. 2009 Feb;20(2):353-7 PMID: 18723550
  13. Hepatocellular carcinoma: focus on different aspects of management.
    ISRN Oncol. 2012;2012:421673 PMID: 22655206
  14. Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
    World J Gastroenterol. 2014 Apr 21;20(15):4115-27 PMID: 24764650
  15. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.
    Nature. 1991 Apr 4;350(6317):429-31 PMID: 1672732
  16. Review article: the management of hepatocellular carcinoma.
    Aliment Pharmacol Ther. 2010 Feb 15;31(4):461-76 PMID: 19925500
  17. Diagnosis and treatment of hepatocellular carcinoma.
    Gastroenterology. 2008 May;134(6):1752-63 PMID: 18471552
  18. Hepatitis C virus infection: molecular pathways to metabolic syndrome.
    Hepatology. 2008 Jun;47(6):2127-33 PMID: 18446789
  19. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients.
    Br J Cancer. 2005 May 23;92(10):1862-8 PMID: 15870713
  20. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
    Hepatology. 2008 Jan;47(1):82-9 PMID: 18008357
  21. Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies.
    Biomed Res Int. 2014;2014:203693 PMID: 25089265
  22. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.
    Gastroenterology. 2007 Jun;132(7):2557-76 PMID: 17570226
  23. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women.
    Am J Epidemiol. 2002 Feb 15;155(4):323-31 PMID: 11836196
  24. CT and MR imaging of hepatocellular carcinoma.
    J Gastrointestin Liver Dis. 2011 Jun;20(2):181-9 PMID: 21725516
  25. Staging systems in hepatocellular carcinoma.
    HPB (Oxford). 2005;7(1):35-41 PMID: 18333159
  26. Hepatocellular carcinoma.
    N Engl J Med. 2011 Sep 22;365(12):1118-27 PMID: 21992124
  27. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.
    Oncologist. 2010;15 Suppl 4:5-13 PMID: 21115576
  28. Management of hepatocellular carcinoma.
    Hepatology. 2005 Nov;42(5):1208-36 PMID: 16250051
  29. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.
    J Hepatol. 2012 Apr;56(4):908-43 PMID: 22424438
  30. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation.
    Am Fam Physician. 2006 Sep 1;74(5):756-62 PMID: 16970019
  31. The etiology of hepatocellular carcinoma and consequences for treatment.
    Oncologist. 2010;15 Suppl 4:14-22 PMID: 21115577
Article Info
Journal
Open access Macedonian journal of medical sciences
Abbr.
Open Access Maced J Med Sci
ISSN
1857-9655
DOI
10.3889/oamjms.2015.111
Published
2015-12-15
Epub
2015-00-29
Pages
732-6
Language
English
Region
North Macedonia
NLM ID
101662294
PMCID
PMC4877918
External Links
PubMed source DOI: 10.3889/oamjms.2015.111 PMC Full Text
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2